Fibrosis & Cirrhosis
Coverage of the 2015 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Monday, 23 November 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2015 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in San Francisco, November 13-17, 2015.
Conference highlights include interferon-free therapy for hepatitis C, treatment for difficult-to-treat populations including people with HCV genotype 3 and liver cirrhosis, hepatitis B prevention and treatment, and management of advanced liver disease.
11/23/15
AASLD 2015: Liver Fibrosis Improves after Successful Treatment for Chronic Hepatitis C
- Details
- Category: HCV Disease Progression
- Published on Thursday, 19 November 2015 00:00
- Written by Liz Highleyman
A majority of chronic hepatitis C patients with advanced fibrosis or cirrhosis showed improvement in liver health following treatment, according to study findings presented at the 2015 AASLD Liver Meeting this week in San Francisco. However, the researchers identified few demographic, laboratory, or disease-related factors that could predict who would experience fibrosis regression and who would have worsening liver damage.
Liver Cirrhosis Is More Common in U.S. than Previously Believed
- Details
- Category: Fibrosis & Cirrhosis
- Published on Thursday, 05 February 2015 00:00
- Written by HIVandHepatitis.com
New estimates indicate that more than 600,000 people in the U.S. have liver cirrhosis -- about 200,000 more than previously thought -- according to a study published online in the Journal of Clinical Gastroenterology. Cirrhosis was associated with hepatitis C virus (HCV) infection, heavy alcohol use, and diabetes.
AASLD 2015: People with Cirrhosis Cured of Hepatitis C Still Have Elevated Liver Cancer Risk
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 17 November 2015 00:00
- Written by Keith Alcorn
The burden of liver cancer and cirrhosis caused by hepatitis C virus (HCV) is likely to continue to grow in the U.S. despite curative treatment, and people who have cirrhosis at the time they are cured of hepatitis C will require long-term monitoring for liver cancer, studies presented this week at the AASLD Liver Meeting in San Francisco show.
10. Hepatitis C Cures for HIV/HCV Coinfected and Advanced Liver Disease
- Details
- Category: Fibrosis & Cirrhosis
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
New interferon-free direct-acting antiviral regimens have high cure rates for chronic hepatitis C patients who were previously considered "difficult to treat," including HIV/HCV coinfected people and patients with liver cirrhosis, decompensated liver disease, and liver transplant recipients. New treatment can now cure a majority of people even with multiple negative predictive factors.